Background illustration for clinical trials search

Paid Clinical Trials Huntsville

Discover 90 paid clinical trials in Huntsville, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

for
Focal Seizure, Epilepsy, Focal Epilepsy
Location: Huntsville AL, Nashville TN, Bentonville AR, Raleigh NC,
Sponsor: Rapport Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT07594119

Phase 3, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Huntsville AL, Cullman AL, Spring Hill TN, Franklin TN,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

for
Type II Diabetes Mellitus
Location: Huntsville AL, Birmingham AL, Fayetteville GA,
Sponsor: Corxel Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07340320

Phase 2, Recruiting

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

for
Excessive Sleepiness, Shift-work Disorder
Location: Auburn AL, Cullman AL, Atlanta GA, Stockbridge GA,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06568367

Phase 3, Recruiting

Effects of Ashwagandha Extract on Stress Levels

for
Stress
Location: Huntsville AL
Sponsor: Nutraceuticals Research Institute

Sex: Female

Age: 30 - 59

Code: NCT06793891

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Athens AL, Tullahoma TN, Chattanooga TN, Birmingham AL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for
Irritable Bowel Syndrome
Location: Guntersville AL, Chattanooga TN, Anniston AL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07519395

Phase 2, Recruiting

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

for
Pneumococcal Disease
Location: Guntersville AL, Tullahoma TN, Birmingham AL,
Sponsor: Pfizer

Sex: All

Age: 1 - 17

Code: NCT07660198

Phase 3, Recruiting

Clinical Validation of ThyroidPrint: A Gene Expression Signature for Diagnosis of Indeterminate Thyroid Nodules

for
Indeterminate Thyroid Cytology
Location: Guntersville AL, Cincinnati OH, New Orleans LA,
Sponsor: Pontificia Universidad Catolica de Chile

Sex: All

Age: 18+

Code: NCT03309631

Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for
Relapsing Multiple Sclerosis
Location: Cullman AL, Birmingham AL, Atlanta GA, Knoxville TN,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase 3, Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

for
Overweight, Obesity
Location: Cullman AL, Birmingham AL, Dunwoody GA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07282600

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

for
Influenza
Location: Cullman AL, Anniston AL, Atlanta GA, Stockbridge GA,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 12+

Code: NCT07159763

Phase 3, Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Cullman AL, Atlanta GA, Decatur GA, Bowling Green KY,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06878261

Phase 3, Recruiting

Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19

for
Coronavirus Disease 2019
Location: Cullman AL, Bradenton FL, Dallas TX, Irving TX,
Sponsor: SyneuRx International (Taiwan) Corp

Sex: All

Age: 18 - 64

Code: NCT04911777

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

for
Narcolepsy Type 1
Location: Cullman AL, Macon GA, Columbia SC, Charlotte NC,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT07455383

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

for
Narcolepsy Type 2
Location: Cullman AL, Stockbridge GA, Macon GA, Columbia SC,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT07502443

Phase 3, Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Cullman AL, Atlanta GA, Stockbridge GA, Macon GA,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06767683

Phase 2, Phase 3, Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Cullman AL, Tullahoma TN, Chattanooga TN, Franklin TN,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06283966

Phase 3, Recruiting

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for
Peripheral Artery Disease (PAD)
Location: Tullahoma TN, Alexander City AL, Jackson TN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase 3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Shelbyville TN, Chattanooga TN, Birmingham AL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase 3, Recruiting